These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2887330)

  • 1. Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitus.
    Berntorp E; Berntorp K; Seiving B; Stenberg P
    Diabetes Res; 1987 May; 5(1):29-33. PubMed ID: 2887330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase-dependent lymphocyte transformation in type 2 diabetes mellitus.
    Berntorp K; Eriksson KF; Berntorp E
    Diabetes Res; 1989 Apr; 10(4):171-4. PubMed ID: 2575478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoke impairment of human lymphocyte function by inhibition of transglutaminase.
    Berntorp K; Ekman M; Berntorp E
    J Intern Med; 1989 Aug; 226(2):73-9. PubMed ID: 2570119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease.
    Stüber E; Noth R; Dirks M; Arendt T; Fölsch U
    J Autoimmun; 2002 Feb; 18(1):1-8. PubMed ID: 11869041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
    Gomis R; Casanovas A; Casamitjana R; Sarto A; Arroyo J; Coves MJ; Rivera F; Vilardell E
    Diabetes Res Clin Pract; 1988 May; 5(1):31-6. PubMed ID: 2900125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deficiency of B-glycosidases in leukocytes from patients with non-insulin dependent diabetes mellitus.
    Moszczyński P; Lisiewicz J; Palimaka W
    Med Interne; 1985; 23(4):265-9. PubMed ID: 4089500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
    Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS
    J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta 2 microglobulin in diabetic patients. Apropos of 190 subjects].
    Dauzat J; Moinade S; Gaillard G
    Sem Hop; 1984 Mar; 60(11):745-8. PubMed ID: 6324352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRPLA aggregation and transglutaminase, revisited.
    Lorand L
    Nat Genet; 1998 Nov; 20(3):231. PubMed ID: 9806539
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.
    Vitkovsky Y; Kuznik B; Solpov A; Magen E
    Isr Med Assoc J; 2008 Oct; 10(10):691-4. PubMed ID: 19009947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene.
    Mantskava M; Momtselidze N; Pargalava N; Mchedlishvili G
    Clin Hemorheol Microcirc; 2006; 35(1-2):307-10. PubMed ID: 16899949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
    Mazurov VI; Novik AA; Nagibovich OA; Romashevskiĭ BV; Guliaeva IV; Kurganova TA
    Klin Med (Mosk); 1998; 76(6):38-41. PubMed ID: 9693499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum beta 2 microglobulin assay in diabetes mellitus (author's transl)].
    Schlienger JL; Reiss D; Anceau A; Simon C; Stephan F
    Sem Hop; 1982 Apr; 58(16):959-62. PubMed ID: 6178166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
    Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
    J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.
    Igarashi S; Koide R; Shimohata T; Yamada M; Hayashi Y; Takano H; Date H; Oyake M; Sato T; Sato A; Egawa S; Ikeuchi T; Tanaka H; Nakano R; Tanaka K; Hozumi I; Inuzuka T; Takahashi H; Tsuji S
    Nat Genet; 1998 Feb; 18(2):111-7. PubMed ID: 9462738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.